Search

everythinglearnresearchcommunity

for

Search:↓

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Finasteride effectively treats baldness but may cause sexual side effects.

Both estrogens and androgens are important for health in both males and females.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

New treatments for male hypogonadism are effective and should be personalized.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

Some hair loss can be treated, especially in women due to nutrition, but some types remain untreatable.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Finasteride and minoxidil work best together for hair loss.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Estrogen affects scalp cell types differently, enhancing some wound healing processes.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Testosterone protects female heart cells from stress by activating estrogen receptors.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

The cause of atypical Cushing's syndrome in dogs, possibly linked to sex hormones, is not yet proven.

Hormonal therapies help treat female hair loss, but results are slow and vary.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.